Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC)
Clinical trial NCT02609048 · TERMINATED
Trial details
- NCT number
- NCT02609048
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-04
- Primary completion
- 2016-07-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.